Faylene Anne Lunn

Faylene practises intellectual property law with a focus on patent litigation, including proceedings under the Patented Medicine (Notice of Compliance) Regulations . Faylene has been involved in assisting clients on protecting and enforcing their patent portfolios in multiple jurisdictions. She also regularly prepares infringement, validity and freedom-to-operate opinions, particularly in respect of pharmaceutical patents.

A trained scientist with a doctorate in biochemistry and molecular biology from Dalhousie University, Faylene has had her scientific work in enzymology, organic chemistry, molecular biology and microbiology published in peer-reviewed journals and has presented at national and international chemistry conferences.

Teva Canada in the Federal Court’s strike of judicial review by Novo Nordisk Canada Inc.

Federal Court Rules in Favour of Mylan Pharmaceuticals ULC in Pantoprazole Magnesium Patent Case

We explain why IP matters, translate practical hygiene habits into your standard operations and spotlight the pitfalls that quietly erode protection...

A strategic approach to intellectual property and regulatory vigilance can give companies a competitive edge in this rapidly growing industry.